
Currently out of the existing stock ratings of Laura Prendergast, 39 are a BUY (95.12%), 2 are a HOLD (4.88%).
Analyst Laura Prendergast, currently employed at STIFEL, has had 31.49% of price targets met with an average potential upside of 23.2%, reached in 49 days on average. Previously, Laura Prendergast worked at RAYMOND JAMES.
Laura Prendergast has documented 81 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OLMA, Olema Pharmaceuticals at 14-Sep-2026.
Analyst best performing recommendations are on ERAS (ERASCA).
The best stock recommendation documented was for ERAS (ERASCA) on 1/12/2026. The price target of $10 was fulfilled within 9 days with a profit of $3.77 (60.51%), with a performance score of 67.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 22-Nov-2023
$11
$9.53 (648.30%)
$11
20 days ago
(29-Oct-2026)
0/14 (0%)
$9.14 (491.40%)
Buy Since 30-Sep-2025
$7
$5.53 (376.19%)
$6
7 months 26 days ago
(23-Mar-2026)
0/2 (0%)
$4.85 (225.58%)
Buy Since 12-Sep-2023
$14
$12.53 (852.38%)
$16
8 months 1 days ago
(17-Mar-2026)
0/11 (0%)
$11.77 (527.80%)
Buy Since 18-Nov-2025
$8
$6.53 (444.22%)
$9
10 months 2 days ago
(16-Jan-2026)
0/2 (0%)
$5.44 (212.50%)
Buy Since 14-Dec-2023
11 months 14 days ago
(04-Dec-2025)
1/6 (16.67%)
$5.12 (177.78%)
83
Which stock is Laura Prendergast most bullish on?
Which stock is Laura Prendergast most reserved on?
What Year was the first public recommendation made by Laura Prendergast?